Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
about
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsAn animal model of emotional blunting in schizophrenia.Schizophrenia: redox regulation and volume neurotransmissionGlutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex.Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamsterPharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.Contrasting effects of nitric oxide and corticotropin- releasing factor within the dorsal periaqueductal gray on defensive behavior and nociception in mice.The role of substance P in epilepsy and seizure disorders.Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.Effects of 1.8 GHz Radiofrequency Fields on the Emotional Behavior and Spatial Memory of Adolescent Mice.Chlorpyrifos increases the levels of hippocampal NMDA receptor subunits NR2A and NR2B in juvenile and adult rats.Aspirin increases NMDA receptor subunit 2A concentrations in rat hippocampus.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
P2860
Q28079065-803FA5A0-5924-4608-AD43-7D71772C78A3Q28471824-22D7E600-27E7-4B64-AA8C-626C7A9E76A0Q28742799-7DF39DFA-C926-425C-A77E-ED5798819BD1Q33874713-B50156B7-F601-4F5B-972A-98AE42B5C13BQ35747079-761AB6BE-7849-4229-A6E0-AB552BB553ABQ36918039-CF524300-A60B-458E-BF4D-275E9014E4D5Q38917991-6AE348A6-C257-40C9-B02E-91BD76FB8373Q42839401-0756E17E-CFC2-45B5-8511-B6C7CDA2E74BQ44221614-7EA6A710-C0A9-4F2C-9874-7724B4D106C8Q46507878-F6FBF25E-E55E-4571-BBB7-173FB4A10937Q46913948-CA7BF12D-45E9-4D4C-BE86-2DF4B00F435AQ47109510-A541088F-6531-4070-9D5F-3E629C6A0697Q48238841-890D9C30-4B98-4668-AD0B-56963BD88675Q48775929-77848E03-D363-4588-90E2-1ECBB655F864Q57491589-FC5D60D4-C89C-4017-BB8D-CF622E10C16D
P2860
Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@ast
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@en
type
label
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@ast
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@en
prefLabel
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@ast
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@en
P1476
Glutamatergic neurotransmissio ...... of antipsychotic atypicality.
@en
P2093
Uriel Heresco-Levy
P304
P356
10.1016/J.PNPBP.2003.09.007
P577
2003-10-01T00:00:00Z